The 22nd Annual Meeting of the Oligonucleotide Therapeutics Society (OTS Meeting) takes place in Denver, US on October 11-14. The meeting brings together scientists across academia, industry, government, and clinical practice to connect, share advances, and shape the future of oligonucleotide therapeutics.
At the meeting, Cellectricon we will present a poster titled:
Assessment of acute and delayed onset toxicity effects of oligonucleotides using in vitro neuronal models
Poster number: P160
If you are interested in learning more about Cellectricon’s neuroscience drug discovery services, stop by the poster or reach out to setup a meeting with our CSO, Johan Pihl.
Johan Pihl, CSO
Meet us at the OTS Meeting!
We are excited for this year’s conference and to meet with clients and fellow researchers. Get in touch to setup a meeting if you are interested in learning more about Cellectricon’s in vitro neurobiology research services.